HARP

Harpoon Therapeutics, Inc. Common Stock

Delisted

HARP was delisted on the 8th of March, 2024.

84 hedge funds and large institutions have $196M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$463K
Puts
$457K
Net Calls
Net Calls Change

Top Buyers

1 +$14.6M
2 +$4.91M
3 +$2.42M
4
O
OrbiMed
New York
+$2.21M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.81M

Top Sellers

1 -$9.41M
2 -$3.78M
3 -$2.64M
4
LCM
Laurion Capital Management
New York
-$2.42M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.18M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$24.1M
2
$23.8M
3
$23.6M
4
$21.9M
5
$14.6M
6
$12.9M
7
$9.47M
8
$9.15M
9
$7.55M
10
$6.11M
11
$4.91M
12
$4.08M
13
$3.59M
14
$3.15M
15
$2.9M
16
$2.47M
17
$1.78M
18
$1.77M
19
$1.62M
20
$1.54M
21
$1.44M
22
$980K
23
$965K
24
$887K
25
$847K